Vitrolife
250 SEK +0,89%2 investorer følger denne virksomhed
Vitrolife is a global provider of solutions in the field of reproductive health. The company develops, manufactures, and distributes medical devices and provides genetic testing services for IVF clinics and their patients. Its mission is to support IVF clinics in enhancing their practice as well as the outcome of a patient’s fertility treatment. Vitrolife´s products and services are available globally, and the company is headquartered in Gothenburg, Sweden.
Omsætning
-
EBIT %
-
P/E
-
Udbytteafkast, %
-
Kursmål
-
Anbefaling
-
Opdateret
-
NASDAQ Stockholm
VITR
Daglig lav / høj pris
245,6 / 253,2
SEK
Markedsværdi
33,86 mia. SEK
Aktieomsætning
21,38 mio. SEK
Volumen
86 t
Finanskalender
Delårsrapport
24.10.2024
Årsrapport
30.01.2025
Delårsrapport
16.04.2025
Generalforsamling
29.04.2025
Delårsrapport
16.07.2025
Større aktionærerKilde: Millistream Market Data AB
| Ejer | Kapital | Stemmer |
|---|---|---|
| William Demant Invest | 28,7 % | 28,7 % |
| Bure Equity | 15,9 % | 15,9 % |
| AMF - Försäkring Och Fonder | 5,3 % | 5,3 % |
| Fjärde AP-Fonden | 3,6 % | 3,6 % |
| Swedbank Robur Fonder | 3,6 % | 3,6 % |
| State Street Bank & Trust Co. | 3,3 % | 3,3 % |
| BNY Mellon SA/NV (Former BNY), W8IMY | 3,2 % | 3,2 % |
| J.P. Morgan Bank Luxembourg S.A. | 1,9 % | 1,9 % |
| Cliens Fonder | 1,8 % | 1,8 % |
| Handelsbanken Fonder | 1,6 % | 1,6 % |
ViserAlle indholdstyper
Vitrolife AB (publ): Interim report Q2, 2024: Strong Technologies growth and improved margins
Vitrolife AB (publ): Conference call interim report
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools